Corcept Therapeutics Inc SEC Filings

Form 4 Overview – Global Net Lease (GNL)

Director Leslie D. Michelson reported the acquisition of 4,801 shares of GNL common stock on 07/01/2025. The shares were issued under the company’s 2025 Omnibus Incentive Compensation Plan as part of the director’s annual cash retainer, which Michelson elected to receive in equity. The filing lists an implied grant value of $7.55 per share.

Following the award, Michelson’s direct beneficial ownership increases to 104,278 shares. No derivative securities were involved and no dispositions were reported.

Because the transaction is a routine, in-lieu-of-cash stock grant rather than an open-market purchase, the market impact is expected to be minimal. Nonetheless, the additional equity slightly deepens insider alignment with shareholder interests.

Global Net Lease, Inc. (GNL) – Form 4 insider transaction

Director Portia Sue Perrotty acquired 4,667 common shares on 07/01/2025. The shares were issued at an indicated value of $7.55 each under the company’s 2025 Omnibus Incentive Compensation Plan, replacing a portion of her annual cash retainer for board and committee service.

After the grant, the director’s directly held stake increases to 115,661 shares. No shares were sold and no derivative securities were involved.

• Transaction code: A (award/award-related acquisition)
• Estimated grant value: ≈ $35,000 (4,667 × $7.55)
• Ownership classification: Direct

The award modestly deepens insider equity alignment but, being compensation-related rather than an open-market purchase, carries limited market-moving weight.

JPMorgan Chase Financial Company LLC is offering $435,000 of three-year Capped Digital Notes linked to the J.P. Morgan Dynamic Blend^SM Index (ticker: JPUSDYBL Index). The notes price at 100% of face value ($1,000 minimum denomination) and settle on or about 2 July 2025, maturing 30 June 2028. JPMorgan Chase & Co. provides a full and unconditional guarantee, but the notes remain senior unsecured obligations subject to the credit risk of both entities.

Payout structure

• If the Index’s Final Value ≥ Initial Value (149.94), investors receive principal plus a fixed 24.00% Contingent Digital Return ($1,240 per $1,000 note).
• If the Final Value is below the Initial Value, holders receive only par ($1,000). No interest is paid during the term.

Economics & fees

• Price to public: 100%  |  Selling commissions: 2.5% ($25 per $1,000)  |  Proceeds to issuer: 97.5%.
• Estimated value at pricing was $945.70 per $1,000, 5.4% below issue price, reflecting embedded costs and hedging.
• The Index deducts an explicit 0.95% p.a. fee and targets 3% volatility by dynamically reallocating between S&P 500 futures (equity) and 2-year Treasury futures (bond). Frequent rebalancing and the low volatility target can mute equity upside.

Key risks disclosed

• Credit risk of JPMorgan entities; the notes are not FDIC-insured.
• No secondary-market listing; liquidity will depend on J.P. Morgan Securities’ bid, likely below issue price.
• Upside cap (24%) and index fee drag may cause returns to lag direct equity exposure.
• The estimated value relies on an internal funding rate and may differ from observable market prices.

The product suits investors seeking principal protection at maturity and willing to exchange uncapped market participation for a predefined 24% payoff if the index is flat or rises. It does not materially affect JPMorgan Chase & Co.’s financial position given its de-minimis size, but it offers retail investors a structured way to gain conditional exposure to a proprietary, low-volatility index.

On July 1, 2025, Dogwood Therapeutics, Inc. (ticker DWTX) filed a Form 4 disclosing that its Chief Executive Officer and Director, Gregory Scott Duncan, received a grant of 40,000 stock options on June 27, 2025. The options carry an exercise price of $4.71 per share, become exercisable one-third on June 27, 2026, and thereafter vest in equal monthly installments over 24 months, with an expiration date of June 27, 2035. Following this grant, Mr. Duncan beneficially owns 40,000 derivative securities directly. No shares of common stock were bought or sold, and there were no disposals of derivative securities. The filing represents routine executive compensation disclosure rather than a market-moving transaction.

Royal Bank of Canada (RY) is marketing five separate Auto-Callable Contingent Coupon Barrier Notes with a “memory” coupon that mature on July 20, 2028 and are linked individually to ON Semiconductor (ON), Schlumberger (SLB), Tesla (TSLA), Vistra (VST) and XPO Logistics (XPO). Investors buy in $1,000 denominations and may choose any combination of the offerings.

Income mechanics: Each note pays a quarterly contingent coupon of roughly 9.5%-15% per annum if on the observation date the underlier closes at or above a “coupon threshold” that equals the barrier value. Missed coupons can be “made up” later under the memory feature.

Auto-call: Beginning six months after issuance, if the underlier closes at or above its initial value on any observation date, the note is automatically redeemed at par plus any due coupons.

Principal repayment: If not called, holders receive at maturity (i) par plus any coupons if the final underlier value is at least the barrier level (50%-70% of initial, security-specific); or (ii) par reduced 1% for every 1% the underlier is below its initial value if the barrier is breached—putting up to 100% of principal at risk.

Pricing & distribution: Offer price is 100%, but the initial estimated value is $886-$950 per $1,000, reflecting a ~5%-11% fee/hedging drag. RBC Capital Markets is sole book-runner; the notes will not be exchange-listed and secondary liquidity is expected to be thin.

Key risks highlighted include

• full downside exposure below barrier
• uncertain coupon stream and capped upside
• issuer credit risk
• illiquidity and potential large bid-ask spreads
• uncertain U.S. tax treatment and possible withholding for non-U.S. investors.

Overall, the product offers above-market coupon potential in exchange for equity downside risk and limited upside participation, suitable only for investors who understand structured-note mechanics and RBC credit exposure.

On June 17, 2025, Stardust Power Inc. (SDST) signed an Underwriting Agreement with Aegis Capital Corp. for a firm-commitment public offering of 21,500,000 common shares at $0.20 per share. Gross proceeds total approximately $4.3 million before underwriting discounts and offering expenses, with an additional 45-day over-allotment option for up to 3,225,000 shares.

The shares were issued under the Company’s Form S-1 (File No. 333-287939) declared effective on June 16, 2025; closing for the Firm Shares occurred on June 18, 2025. Net proceeds are earmarked to complete the Definitive Feasibility Study (DFS/FEL-3) for the proposed lithium processing facility in Muskogee, Oklahoma, supporting the Company’s strategy to become a domestic lithium supplier.

The Underwriting Agreement includes standard representations, warranties, indemnification, and termination provisions and is filed as Exhibit 1.1. Press releases covering pricing (June 17) and closing (June 18) are attached as Exhibits 99.1 and 99.2, respectively.

This capital raise supplies near-term liquidity for project development but also introduces material shareholder dilution at a relatively low offering price, indicating a higher cost of capital for the Company and underscoring the importance of executing the DFS on schedule.